​

Funding Round

Series A - Mersana Therapeutics

Series A - Mersana Therapeutics

Investment Firm

Overview

Mersana Therapeutics develops a biodegradable polymer platform Fleximer® which creates new and better medicines.

Announced Date

Jul 31, 2012

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

New Enterprise Associates

New Enterprise Associates

New Enterprise Associates is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and venture firm.

Participant Investors

5

Investor Name
Participant InvestorPfizer Venture Investments
Participant InvestorProQuest Investments
Participant InvestorRho Ventures
Participant InvestorF-Prime Capital
Participant InvestorNew Enterprise Associates

Round Details and Background

Mersana Therapeutics raised $27000000 on 2012-07-31 in Series A

Mersana Therapeutics develops a biodegradable polymer platform Fleximer® which creates new and better medicines.

Company Funding History

12

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 08, 2014
Series A - Mersana Therapeutics
2-14.5M
Apr 18, 2012
Debt Financing - Mersana Therapeutics
-10.0M
Jul 31, 2012
Series A - Mersana Therapeutics
6-27.0M
Nov 08, 2005
Venture Round - Mersana Therapeutics
8-21.0M

Recent Activity

There is no recent news or activity for this profile.